Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04723563 · ClinicalTrials.gov registry record · Phase 4
Nebulized Heparin for the Treatment of COVID-19
A Phase 4 study of Covid19 and Pneumonia, Viral, sponsored by Frederick Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04723563 is a Phase 4 study of Covid19 and Pneumonia, Viral that has completed, run by Frederick Health. The registered enrollment target is 50 participants, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04723563, a Phase 4 study of Covid19 and Pneumonia, Viral, has completed, sponsored by Frederick Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized, placebo controlled study to determine if nebulized heparin may reduce the need for mechanical ventilation in hospitalized patients with the novel coronavirus, also known as COVID-19. This will be a part of a larger meta-trial.
Conditions Studied
Interventions
- DRUG 0.9%sodium chloride
- DRUG Heparin
Study Locations (1)
Maryland
- Frederick Health Hospital - Frederick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-02-22 |
| Est. Completion | 2021-08-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04723563
The ClinicalTrials.gov registry entry for NCT04723563 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (98% lower). The listed sponsor is Frederick Health, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Covid19 appearing as the primary indexed condition, and to 2 interventions - of which 0.9%sodium chloride is the first listed.
NCT04723563 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04723563 about?
NCT04723563 is a clinical study titled "Nebulized Heparin for the Treatment of COVID-19". Randomized, placebo controlled study to determine if nebulized heparin may reduce the need for mechanical ventilation in hospitalized patients with the novel coronavirus, also known as COVID-19. This will be a part of a larger meta-trial.
What is the current status of trial NCT04723563?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2021-02-22. Estimated completion is 2021-08-23.
What conditions does trial NCT04723563 study?
This clinical trial studies the following conditions: Covid19, Pneumonia, Viral.
What interventions are being tested in trial NCT04723563?
The interventions under investigation include: 0.9%sodium chloride (DRUG), Heparin (DRUG).
Who is sponsoring clinical trial NCT04723563?
This trial is sponsored by Frederick Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04723563 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparing the Effects of Different Doses of Dexamethasone to Treat Inpatient COVID-19
COMPLETED · Phase 4
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.